Ruoyu Huang
Ruoyu Huang
1
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
2
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3
Chinese Glioma Cooperative Group (CGCG), Beijing, China
1,2,3,
Guanzhang Li
Guanzhang Li
1
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
2
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3
Chinese Glioma Cooperative Group (CGCG), Beijing, China
1,2,3,
Kuanyu Wang
Kuanyu Wang
3
Chinese Glioma Cooperative Group (CGCG), Beijing, China
4
Department of Gamma Knife Center, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
3,4,
Zhiliang Wang
Zhiliang Wang
1
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
2
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3
Chinese Glioma Cooperative Group (CGCG), Beijing, China
1,2,3,
Fan Zeng
Fan Zeng
1
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
3
Chinese Glioma Cooperative Group (CGCG), Beijing, China
1,3,
Huimin Hu
Huimin Hu
1
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
3
Chinese Glioma Cooperative Group (CGCG), Beijing, China
1,3,*,
Tao Jiang
Tao Jiang
1
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
2
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3
Chinese Glioma Cooperative Group (CGCG), Beijing, China
1,2,3,*
1
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
2
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3
Chinese Glioma Cooperative Group (CGCG), Beijing, China
4
Department of Gamma Knife Center, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
✉*Correspondence: Huimin Hu, huhm_bjni@163.com; Tao Jiang, taojiang1964@163.com
This article was submitted to Molecular and Cellular Pathology, a section of the journal Frontiers in Cell and Developmental Biology
Received 2022 Mar 28; Accepted 2022 Aug 31; Collection date 2022.
Keywords: glioma, ER stress, signature, prognosis, tumor immune environment
Copyright © 2022 Huang, Li, Wang, Wang, Zeng, Hu and Jiang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.